DE69527742T2 - Pharmazeutische Zusammensetzung enthaltend Farnextrakt(e) zur Behandlung von neurodegenerativen Krankheiten. - Google Patents

Pharmazeutische Zusammensetzung enthaltend Farnextrakt(e) zur Behandlung von neurodegenerativen Krankheiten.

Info

Publication number
DE69527742T2
DE69527742T2 DE69527742T DE69527742T DE69527742T2 DE 69527742 T2 DE69527742 T2 DE 69527742T2 DE 69527742 T DE69527742 T DE 69527742T DE 69527742 T DE69527742 T DE 69527742T DE 69527742 T2 DE69527742 T2 DE 69527742T2
Authority
DE
Germany
Prior art keywords
polypodium
treatment
pharmaceutical composition
composition containing
neurodegenerative diseases
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69527742T
Other languages
English (en)
Other versions
DE69527742D1 (de
Inventor
Almagro Eliseo Quintanilla
Alperi Joaquin Diaz
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Especialidades Farmaceuticas Centrum SA
Original Assignee
Especialidades Farmaceuticas Centrum SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from ES9400957A external-priority patent/ES2068163B1/es
Priority claimed from ES9500363A external-priority patent/ES2088770B1/es
Application filed by Especialidades Farmaceuticas Centrum SA filed Critical Especialidades Farmaceuticas Centrum SA
Application granted granted Critical
Publication of DE69527742D1 publication Critical patent/DE69527742D1/de
Publication of DE69527742T2 publication Critical patent/DE69527742T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/11—Pteridophyta or Filicophyta (ferns)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/11—Pteridophyta or Filicophyta (ferns)
    • A61K36/12—Filicopsida or Pteridopsida
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Mycology (AREA)
  • Medical Informatics (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Botany (AREA)
  • Biotechnology (AREA)
  • Epidemiology (AREA)
  • Microbiology (AREA)
  • Neurology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
DE69527742T 1994-05-06 1995-04-27 Pharmazeutische Zusammensetzung enthaltend Farnextrakt(e) zur Behandlung von neurodegenerativen Krankheiten. Expired - Fee Related DE69527742T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
ES9400957A ES2068163B1 (es) 1994-05-06 1994-05-06 Procedimiento de obtencion de un extracto vegetal con actividad en el tratamiento de disfunciones cognitivas y/o neuroinmunes.
ES9500363A ES2088770B1 (es) 1995-02-23 1995-02-23 Una composicion farmaceutica con actividad en el tratamiento de disfunciones cognitivas y/o neuroinmunes.

Publications (2)

Publication Number Publication Date
DE69527742D1 DE69527742D1 (de) 2002-09-19
DE69527742T2 true DE69527742T2 (de) 2002-12-05

Family

ID=26154787

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69527742T Expired - Fee Related DE69527742T2 (de) 1994-05-06 1995-04-27 Pharmazeutische Zusammensetzung enthaltend Farnextrakt(e) zur Behandlung von neurodegenerativen Krankheiten.

Country Status (7)

Country Link
US (1) US5601829A (de)
EP (1) EP0680762B1 (de)
JP (1) JP2779780B2 (de)
AT (1) ATE222112T1 (de)
DE (1) DE69527742T2 (de)
DK (1) DK0680762T3 (de)
PT (1) PT680762E (de)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6228366B1 (en) * 1998-07-29 2001-05-08 Helsint, S.A.L. Water-soluble fractions of Phlebodium decumanum and its use as nutritional supplement in AIDS and cancer patients
US8143234B2 (en) * 1998-07-31 2012-03-27 Massachusetts Institute Of Technology Uridine administration improves phosphatide synthesis, synaptic transmission and cognitive function
US20050203053A1 (en) * 1999-07-30 2005-09-15 Wurtman Richard J. Uridine administration improves phosphatide synthesis, synaptic transmission and cogntive function
US20070004670A1 (en) * 1998-07-31 2007-01-04 Richard Wurtman Compositions containing citicoline, and methods of use thereof
US8314064B2 (en) 1998-07-31 2012-11-20 Massachusetts Institute Of Technology Uridine administration stimulates membrane production
US8518882B2 (en) * 1998-07-31 2013-08-27 Massachusetts Institute Of Technology Methods and compositions for ameliorating or inhibiting decline in memory or intelligence or improving same
ES2147163B1 (es) * 1999-01-25 2001-03-01 Esp Farmaceuticas Centrum Sa Una composicion farmaceutica con actividad reguladora de la expresion de las moleculas de adhesion.
US20040103447A1 (en) * 2001-02-27 2004-05-27 Hiroyuki Nawa Schizophrenia-like mental disease model animal, method of constructing the same and use thereof
US6390979B1 (en) * 2001-08-24 2002-05-21 Philip Chidi Njemanze Noninvasive transcranial Doppler ultrasound computerized mental performance testing system
ES2197018B1 (es) * 2002-06-06 2005-10-01 Especialidades Farmaceuticas Centrum Sa Nuevo uso terapeutico de los extractos de polypodium.
JP4334956B2 (ja) * 2003-09-18 2009-09-30 株式会社ノエビア 細胞賦活剤、美白剤、及び抗酸化剤
PL1762219T3 (pl) † 2004-04-01 2013-06-28 Cantabria Ind Farmaceutica Sa Fotoochronne i/lub fotoimmunoochronne kompozycje do skóry i ich zastosowania
FR2876032B1 (fr) * 2004-10-05 2008-10-31 Greentech Sa Sa Utilisation d'extraits de fougeres dans des preparations cosmetiques ou dermatologiques
CN105510850A (zh) * 2007-11-02 2016-04-20 麻省理工学院 尿苷饮食添加顺应性方法及其用途
KR101478882B1 (ko) 2012-11-28 2015-01-05 경희대학교 산학협력단 고사리삼 추출물을 함유하는 뇌졸중 및 퇴행성 뇌질환의 예방 또는 치료용 약학적 조성물
KR101770871B1 (ko) 2013-12-20 2017-08-24 단국대학교 천안캠퍼스 산학협력단 관중 추출물을 유효성분으로 포함하는 퇴행성 뇌 질환 예방 및 치료용 약제학적 조성물
JP2016204397A (ja) * 2016-09-14 2016-12-08 国立大学法人京都大学 アルツハイマー病予防薬
TWI611806B (zh) * 2016-11-15 2018-01-21 景鑫生物科技股份有限公司 南洋山蘇水萃物的用途

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES470204A1 (es) * 1978-05-24 1979-01-01 Conrad Ltd Procedimiento de obtencion de terpenos naturales con activi-dad antipsoriatica
ES471572A1 (es) * 1978-07-07 1979-01-16 Conrad Ltd Procedimiento de obtencion de fraccion polar natural con ac-tividad antipsoriatica
EP0503208A1 (de) * 1991-03-08 1992-09-16 Maracuyama International, S.A. Verfahren zur Gewinnung eines natürlichen, wasserlöslichen Extraktes von Blättern und/oder Rhizomen aus verschiedenen Farnkräutern mit immunologischer Aktivität

Also Published As

Publication number Publication date
EP0680762A1 (de) 1995-11-08
EP0680762B1 (de) 2002-08-14
JP2779780B2 (ja) 1998-07-23
JPH07304681A (ja) 1995-11-21
PT680762E (pt) 2002-12-31
DK0680762T3 (da) 2002-09-30
DE69527742D1 (de) 2002-09-19
US5601829A (en) 1997-02-11
ATE222112T1 (de) 2002-08-15

Similar Documents

Publication Publication Date Title
DE69527742T2 (de) Pharmazeutische Zusammensetzung enthaltend Farnextrakt(e) zur Behandlung von neurodegenerativen Krankheiten.
Chaudhury Herbal medicine for human health
ATE447391T1 (de) Präparate zur verabreichung von materialien in die haut
AR003989A1 (es) Composicion cosmetica o farmaceutica y procedimiento de tratamiento cosmetico, excluido tdo tratamiento terapeutico que utiliza la composicion cosmetica.
RS49963B (sr) Kompozicija koja obuhvata hranjivi materijal i biljni ekstrat korisna za prevenciju i tretiranje virusa humane imunodeficijencije i drugih infektivnih bolesti
DE59813229D1 (de) Stabiler extrakt aus hypericum perforatum l., verfahren zu seiner herstellung und pharmazeutische zubereitungen
WO1997005899A3 (en) Novel vaccines and pharmaceutical compositions using membrane vesicles of microorganisms, and methods for preparing same
AU6553790A (en) Pharmazeutische praparate
BG102660A (en) Combined pharmaceutical preparation of lhrh-analogues and antiesterogens for the treatment of gynaecological disorders
DE3582594D1 (de) Proglumid und dessen pharmazeutische zusammensetzungen zur anwendung bei der behandlung von neoplastischen affektionen.
ATE204759T1 (de) Verwendung von hyperforin und hyperforinhaltigen extrakten zur behandlung und prophylaxe von demenzerkrankungen
ES2068163B1 (es) Procedimiento de obtencion de un extracto vegetal con actividad en el tratamiento de disfunciones cognitivas y/o neuroinmunes.
ES2088770B1 (es) Una composicion farmaceutica con actividad en el tratamiento de disfunciones cognitivas y/o neuroinmunes.
DE3872881T2 (de) Arzneimittelzusammensetzung zur vorbeugung und behandlung bakterieller und viraler krankheiten.
PL353349A1 (en) Method for isolating and purifying grass pollen allergens
ATE198035T1 (de) Haar-lotion gegen haarausfall und zur förderung des haarwuchses
PT100936A (pt) Sistema de cuidados dos cabelos
ES1034623U (es) Dispositivo para la limpieza de frutos.
RU94036437A (ru) Способ лечения сердечно-сосудистых заболеваний и средство для их лечения
DE3761663D1 (de) In stellung 9(11) gesaettigte und durch ein dreifachbindung enthaltendes radikal substituierte neue steroide, verfahren zu ihrer herstellung, ihre anwendung als heilmittel und diese enthaltende pharmazeutische praeparate.
姚尊华 TREATMENT OF TRICHOMONAL ENTERITIS BY CHINESE MEDICINAL HERBS——REPORT OF 16 CASES
DE60037195D1 (de) Verbindungen zur behandlung von infektionskrankheiten und störungen des immunsystems sowie methoden ihrer anwendung
GEU1997304Y (en) Ointment for Treatment of Skin Fungous Diseases
FR2662081B1 (fr) Extraits de cellules germinales et/ou d'embryons d'amphibiens, leur procede d'obtention et leur utilisation dans des preparations cosmetiques et/ou dermatologiques.
GEU1999425Y (en) Medicinal Ointment “Mdivnishvili -7”

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee